ATL loses round in patent suit
Ultrasound vendor ATL of Bothell, WA, is planning to appeal adecision by the U.S. Court of Appeals for the Federal Districtthat upheld a lower court ruling that it infringed on a patentheld by SRI International of Palo Alto, CA. At issue is a circuitused
Ultrasound vendor ATL of Bothell, WA, is planning to appeal adecision by the U.S. Court of Appeals for the Federal Districtthat upheld a lower court ruling that it infringed on a patentheld by SRI International of Palo Alto, CA. At issue is a circuitused to track ultrasound signals in ATL's Ultramark 4 scanneras well as two discontinued products, Ultramark 5 and ADR 4000(SCAN 2/24/93). The patent expired in April 1994, and ATL saidthat due to the expiration there will be no impact on the company'sability to deliver products.
SRI filed a request for partial summary judgment on its claimin July 1991, and in November 1992 a U.S. district court judgeruled on that motion and determined that ATL had infringed SRI'spatent.
ATL appealed that ruling, but on Dec. 29 announced that theappeals court affirmed the lower court's ruling. ATL said it "willcontinue to seek legal remedies." SRI has claimed $5 millionin damages. A jury trial for the case is pending.
Strategies to Reduce Disparities in Interventional Radiology Care
March 19th 2025In order to help address the geographic, racial, and socioeconomic barriers that limit patient access to interventional radiology (IR) care, these authors recommend a variety of measures ranging from increased patient and physician awareness of IR to mobile IR clinics and improved understanding of social determinants of health.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Study: Monitoring of Prostate MRI Exams Could Lead to 75 Percent Reduction of Gadolinium Contrast
March 17th 2025While DCE MRI was deemed helpful in over 67 percent of cases in which it was used, researchers found that monitored prostate MRI exams, which facilitated a 75 percent reduction of DCE MRI sequences, had comparable sensitivity for prostate cancer as non-monitored exams.
